SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+44.07%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$980M
AUM Growth
+$980M
(+22%)
Cap. Flow
-$118M
Cap. Flow
% of AUM
-12%
Top 10 Holdings %
Top 10 Hldgs %
66.15%
Holding
75
New
12
Increased
8
Reduced
18
Closed
12
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$13M |
| 2 |
Novo Nordisk
NVO
|
$13M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$9.96M |
| 4 |
Halozyme
HALO
|
$6.46M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$5.75M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$58.9M |
| 2 |
PDS Biotechnology
PDSB
|
$20M |
| 3 |
Sanofi
SNY
|
$14.2M |
| 4 |
Gilead Sciences
GILD
|
$13.3M |
| 5 |
Incyte
INCY
|
$11.6M |
Sector Composition
| 1 | Healthcare | 88.82% |
